Haleon files to sell 630M ordinary shares for holders

Pfizer (PFE) is offering 630M ordinary shares in Haleon (HLN) by means of a public offering in the United States of ordinary shares, including ordinary shares in the form of American Depositary Shares, ADSs, each ADS representing two ordinary shares, and a concurrent offer outside the United States of ordinary shares. Haleon is not selling any ordinary shares or ADSs in the global offer, and Haleon will not receive any of the proceeds from the sale of the ordinary shares and ADSs sold by the selling securityholder. The joint global coordinators and joint bookrunners for the offering are Citigroup and Morgan Stanley, and the joint bookrunners are Barclays, J.P. Morgan and UBS Investment Bank.